Drug Profile
Research programme: antibody-mediated thrombosis toleragens - La Jolla Pharmaceutical
Alternative Names: Antithrombotic toleragens - La Jolla PharmaceuticalLatest Information Update: 25 Aug 2022
Price :
$50
*
At a glance
- Originator La Jolla Pharmaceutical Company
- Class Glycoproteins; Polyethylene glycols
- Mechanism of Action B cell inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Autoimmune disorders; Thrombosis